News
By Reuters June 18, 20157:05 AM UTCUpdated ago June 18 (Reuters) - Argen X BV : * Preliminary phase I results of ARGX-110 in patients with t-cell lymphomas presented at ICML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback